The Alexion Antibody Technologies brand, founded in 1997 (United States), from 584 sister brands and 17477 competing brands. The Alexion Antibody Technologies brand is owned by ASTRAZENECA, a company listed in London. Its International Securities Identification Number (ISIN) is GB0009895292. Alexion Antibody Technologies belongs to the Drug Manufacturers business sector.
Investment simulator :
Portfolio valuation
ASTRAZENECA
(Alexion Antibody Technologies)
over 5 years*
GBX 25,210.27